Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
Reza Naghavian, Wolfgang Faigle, Pietro Oldrati, et al.
Nature (2023) Vol. 617, Iss. 7962, pp. 807-817
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 59
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa T. Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 44
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 41
Glioblastoma vaccines: past, present, and opportunities
Zujian Xiong, Itay Raphael, Michael R. Olin, et al.
EBioMedicine (2024) Vol. 100, pp. 104963-104963
Open Access | Times Cited: 28
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Andrew Redenti, Jongwon Im, Benjamin Redenti, et al.
Nature (2024) Vol. 635, Iss. 8038, pp. 453-461
Open Access | Times Cited: 22
Broadening oncological boundaries: the intratumoral microbiota
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 17
Targeting endothelial permeability in the EPR effect
Behnaz Lahooti, Racheal G. Akwii, Fatema Tuz Zahra, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 212-235
Closed Access | Times Cited: 39
Intracellular bacteria in cancer—prospects and debates
Lena Schorr, Marius Mathies, Eran Elinav, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 24
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy
Chin Leng Tan, Katharina A.M. Lindner, Tamara Boschert, et al.
Nature Biotechnology (2024) Vol. 43, Iss. 1, pp. 134-142
Open Access | Times Cited: 15
Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse
Yulin Zhang, Kaiyan Xi, Zhipeng Fu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
Lisa Feldman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Exploring the gut microbiota and its potential as a biomarker in gliomas
Dana Aljarrah, Naima Chalour, Amine Zorgani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116420-116420
Open Access | Times Cited: 10
Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma
Hao Zhang, Ying Hong, Tingting Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
A multi-omics spatial framework for host-microbiome dissection within the intestinal tissue microenvironment
Bokai Zhu, Yunhao Bai, Yao Yu Yeo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies
Aleksandra Krawczyk, Gabriela Elzbieta Sladowska, Barbara Strzałka‐Mrozik
Cancers (2025) Vol. 17, Iss. 5, pp. 719-719
Open Access | Times Cited: 1
Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy
Yuqing Liu, Fan Li, Juanjuan Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study
Chuan Zeng, Chaolong Zhang, Chunming He, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 18
Identification of consensus head and neck cancer-associated microbiota signatures: a systematic review and meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets
Kenny Yeo, Runhao Li, Fangmeinuo Wu, et al.
Journal of Medical Microbiology (2024) Vol. 73, Iss. 2
Open Access | Times Cited: 6
Bacterial Biohybrids for Invasion of Tumor Cells Promote Antigen Cross‐Presentation Through Gap Junction
Wen Li, Qi‐Wen Chen, Jin‐Xuan Fan, et al.
Advanced Materials (2024) Vol. 36, Iss. 25
Closed Access | Times Cited: 6
TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challenges
Elena A. Golikova, Alina Alshevskaya, Saleh Alrhmoun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Cytotoxic CD4+ T cells in chronic viral infections and cancer
Anna Malyshkina, Alicia Brüggemann, Annette Paschen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Microbes in the tumor microenvironment: New Additions to break the Tumor Immunotherapy Dilemma
Lujia Zhou, Shiying Fan, Wenjie Zhang, et al.
Microbiological Research (2024) Vol. 285, pp. 127777-127777
Closed Access | Times Cited: 5
Surface Engineering Enhances Vanadium Carbide MXene‐Based Nanoplatform Triggered by NIR‐II for Cancer Theranostics
Xiaodong Zhu, Xide Zhang, Jiahao Guo, et al.
Small (2024) Vol. 20, Iss. 44
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top